Q2 EPS Estimate for Eli Lilly and Company Reduced by Analyst
Eli Lilly and Company (NYSE:LLY – Free Report) – Equities research analysts at Leerink Partnrs decreased their Q2 2025 earnings per share (EPS) estimates for Eli Lilly and Company in a note issued to investors on Thursday, May 1st. Leerink Partnrs analyst D. Risinger now anticipates that the company will post earnings per share of […]
Eli Lilly and Company (NYSE:LLY – Free Report) – Equities research analysts at Leerink Partnrs decreased their Q2 2025 earnings per share (EPS) estimates for Eli Lilly and Company in a note issued to investors on Thursday, May 1st. Leerink Partnrs analyst D. Risinger now anticipates that the company will post earnings per share of […]
